Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Legge, Francesco ^a,b   Petrillo, Marco ^b   Adamo, Vincenzo ^c   Pisconti, Salvatore ^d   Scambia, Giovanni ^b   Ferrandina, Gabriella ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d Hospital of Taranto   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; PLATINUM COMPLEX; TAXANE DERIVATIVE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; EPITHELIUM CELL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISOLATED LYMPH NODE RECURRENCE; LYMPHADENOPATHY; METASTASIS POTENTIAL; OUTCOME ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PERITONEAL DISEASE; PROGNOSIS; CHI SQUARE DISTRIBUTION; DISEASE COURSE; ITALY; KAPLAN MEIER METHOD; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; OVARY TUMOR; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; HUMANS; ITALY; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 61349116871     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-367     Document Type: Article

References (26)

1. Jemal A Siegel R Ward E Murray T Xu J Thun MJ Cancerstatistics, 2007 CA Cancer J Clin 2007, 57(1):43-66. 17237035
2. Ferrandina G Legge F Salutari V Paglia A Testa A Scambia G Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations Eur J Cancer 2006, 42(14):2296-2302. 10.1016/ j.ejca.2006.03.025 16901687
3. Armstrong D Relapsed ovarian cancer: Challenges andmanagement strategies for a chronic disease The Oncologist 2007, 7:20-28. 10.1634/ theoncologist.7-suppl_5-20
4. Hoskins PJ Eisenhauer EA van Glabbeke M Vermorken J Tu D James K Predicting outcome after initial relapse of epithelial ovarian cancer: can we identify patients who will not benefit from further therapy? CME J Gynecol Oncol 1999, 4:64-69.
5. Onda T Yoshikawa H Yasugi T Yamada M Matsumoto K Taketani Y Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection Br J Cancer 2005, 92(6):1026-1032. 10.1038/sj.bjc.6602466 15770211
6. Harter P du Bois A The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence Curr Opin Oncol 2005, 17(5):505-514. 10.1097/01.cco.0000174166.06734.c7 16093804
7. Blanchard P Plantade A Pages C Isolated lymph node relapse of epithelial ovarian carcinoma: Outcomes and prognostic factors Gynecol Oncol 2007, 104(1):41-45. 10.1016/j.ygyno.2006.06.039 16952391
8. Benedetti Panici P Perniola G Angioli R Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: Impact of surgery Int J Gynecol Cancer 2007, 17(6):1245-1251. 10.1111/j.1525-1438.2007.00929.x 17425680
9. Santillan A Karam AK Li AJ Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer Gynecol Oncol 2007, 104(3):686-690. 10.1016/j.ygyno.2006.10.020 17141302
10. Uzan C Morice P Rey A Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes Ann Surg Oncol 2004, 11(7):658-664. 10.1245/ ASO.2004.11.023 15197013
11. Onda T Yoshikawa H Yasugi T Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to Stage I/II patients and superior survival to other Stage III patients Cancer 1998, 83(8):1555-1560. 10.1002/ (SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R 9781949
12. Ferrandina G Scambia G Legge F Petrillo M Salutari V Ovarian cancer patients with "node- positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B Gynecol Oncol 2007, 107(1):154-156. 10.1016/j.ygyno.2007.05.016 17614126
13. Cliby WA Aletti GD Wilson TO Podratz KC Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol 2006, 103(3):797-801. 10.1016/ j.ygyno.2006.08.047 17052746
14. Herzog TJ Assessing the adequacy of surgical staging for ovarian cancer Gynecol Oncol 2006, 103(3):781-782. 10.1016/j.ygyno.2006.10.017 17141679
15. Baiocchi G Grosso G di Re E Fontanelli R Raspagliesi F di Re F Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer Gynecol Oncol 1998, 69(2):151-156. 10.1006/ gyno.1998.4964 9600823
16. Maggioni A Benedetti Panici P Dell'Anna T Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis Br J Cancer 2006, 95(6):699-704. 10.1038/sj.bjc.6603323 16940979
17. Benedetti Panici P Maggioni A Hacker N Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial J Natl Cancer Inst 2005, 97(8):560-566. 15840878
18. Chambers SK Systematic lymphadenectomy in advanced epithelial ovarian cancer: Two decades of uncertainty resolved J Natl Cancer Inst 2005, 97(8):548-549. 15840870
19. Testa AC Fruscella E Ludovisi M The role of sonographic examination in the follow up of gynecological neoplasms Gynecol Oncol 2005, 99(3):696-703. 10.1016/j.ygyno.2005.07.116 16140365
20. Markman M Recurrence within 6 months of platinum therapy: An adequate definition of 'platinum-refractory' ovarian cancer? Gynecol Oncol 1998, 69:91-92. 10.1006/gyno.1998.4997 9600812
21. Kaplan EL Meier P Nonparametric estimation from incomplete observation J Am Stat Assoc 1958, 53:457-481. 10.2307/2281868
22. Mantel N Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 1966, 50:163-170. 5910392
23. Cox DR Regression models and life tables J Royal Statist Soc 1972, 34:197-220.
24. Morice P Dubernard G Rey A Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer J Am Coll Surg 2003, 197(6):955-963. 10.1016/j.jamcollsurg.2003.06.004 14644284
25. Tan DS Agarwal R Kaye SB Mechanisms of transcoelomic metastasis in ovarian cancer Lancet Oncol 2006, 11:925-934. 10.1016/ S1470-2045(06)70939-1 17081918
26. Bristow RE Giuntoli RL 2nd Pannu HK Schulick RD Fishman EK Wahl RL Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes Gynecol Oncol 2005, 99(2):294-300. 10.1016/ j.ygyno.2005.06.019 16051330